Lighthouse Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.24M Buy
6,515
+238
+4% +$105K 1.68% 19
2026
Q1
$2.8M Buy
6,277
+2,547
+68% +$1.19M 1.69% 18
2025
Q4
$1.69M Hold
3,730
1.11% 21
2025
Q3
$1.46M Hold
3,730
0.96% 22
2025
Q2
$1.66M Hold
3,730
1.27% 20
2025
Q1
$1.81M Buy
3,730
+25
+0.7% +$11.7K 1.56% 16
2024
Q4
$1.49M Buy
+3,705
New +$1.72M 1.21% 21

Other funds holding VRTX

Lighthouse Financial's VRTX Position: Q2 2026 in Review

Lighthouse Financial increased its Vertex Pharmaceuticals (VRTX) stake by 3.8% in Q2 2026, buying an estimated $105K and bringing the position to 6,515 shares worth $3.24M. The position accounts for 1.68% of the portfolio, ranked #19.

Lighthouse Financial first reported a position in VRTX in Q4 2024 and has held it in 7 quarters since. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Lighthouse Financial held 6,515 shares of Vertex Pharmaceuticals worth $3.24M as of Q2 2026.
  • Lighthouse Financial bought 238 Vertex Pharmaceuticals shares in Q2 2026, an estimated $105K.
  • Vertex Pharmaceuticals made up 1.68% of Lighthouse Financial's portfolio in Q2 2026, its #19 holding.
  • Lighthouse Financial first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Lighthouse Financial's 13F filing for Q2 2026, filed 14 Aug 2026.